Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monopolar diathermy versus a vessel-sealing device for reducing postoperative drain output after simple mastectomy: randomized clinical trial.
Keelan S, Dowling GP, Roche T, Hegarty A, Davey MG, Dhannoon AA, O'Grady S, Downey E, Bolger J, Boland M, Sorensen J, Power C, Butt A, Baban C, Hill ADK. Keelan S, et al. Among authors: hill adk. Br J Surg. 2024 Mar 2;111(3):znae029. doi: 10.1093/bjs/znae029. Br J Surg. 2024. PMID: 38498075 Free PMC article. Clinical Trial.
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.
Potter S, Trickey A, Rattay T, O'Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Potter S, et al. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. Br J Surg. 2020. PMID: 32073654
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study).
Dowling GP, Toomey S, Bredin P, Parker I, Mulroe E, Marron J, McLoughlin O, Teiserskiene A, Power C, O'Shea AM, Greally M, Morris PG, Duke D, Hill ADK, Hennessy BT. Dowling GP, et al. Among authors: hill adk. BMC Cancer. 2024 Jan 17;24(1):91. doi: 10.1186/s12885-024-11851-4. BMC Cancer. 2024. PMID: 38233810 Free PMC article.
Impact of Sentinel Lymph Node Biopsy on Management of Older Women With Clinically Node-Negative, Early-Stage, ER+/HER2-, Invasive Breast Cancer: A Systematic Review and Meta-Analysis.
Daly GR, Dowling GP, Said M, Qasem Y, Hembrecht S, Calpin GG, AlRawashdeh MM, Hill ADK. Daly GR, et al. Among authors: hill adk. Clin Breast Cancer. 2024 Dec;24(8):e681-e688.e1. doi: 10.1016/j.clbc.2024.07.012. Epub 2024 Aug 8. Clin Breast Cancer. 2024. PMID: 39214843 Free article. Review.
Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.
Dowling GP, Daly GR, Hegarty A, Flanagan M, Ola M, Fallon R, Cocchiglia S, Singh V, Sheehan KM, Bane F, McGrath J, Watson L, Hembrecht S, Hennessy B, Morris PG, Hill ADK, Varešlija D, Young LS. Dowling GP, et al. Among authors: hill adk. Cancer Commun (Lond). 2024 Dec 15. doi: 10.1002/cac2.12640. Online ahead of print. Cancer Commun (Lond). 2024. PMID: 39676516 No abstract available.
Preoperative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective U.K. database of 8820 patients.
Sutcliffe RP, Hollyman M, Hodson J, Bonney G, Vohra RS, Griffiths EA; CholeS study group, West Midlands Research Collaborative. Sutcliffe RP, et al. HPB (Oxford). 2016 Nov;18(11):922-928. doi: 10.1016/j.hpb.2016.07.015. Epub 2016 Aug 31. HPB (Oxford). 2016. PMID: 27591176 Free PMC article.
215 results